Novo Nordisk to Stop Insulin Sales in Greece


Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a  BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices.

More than 50,000 Greeks with diabetes use Novo Nordisk’s insulin pen products.

Leave a Reply

2 Comment threads
0 Thread replies
Most reacted comment
Hottest comment thread
2 Comment authors
MariosJeff Recent comment authors
newest oldest most voted
Notify of

be it acceptable or not, they are doing it, but the downside is other countries are also supplied from Greece, so this may also effect them, and subsequently me…they are not the only company who supply insulin, so in the long run other people may switch


This is so not acceptable!

Copyright © 2009-2020 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.
DMCA Compliant